KT&G Corp
KRX:033780
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
KT&G Corp
Note Receivable
KT&G Corp
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
KT&G Corp
KRX:033780
|
Note Receivable
₩109.4B
|
CAGR 3-Years
27%
|
CAGR 5-Years
14%
|
CAGR 10-Years
8%
|
|
KT&G Corp
Glance View
KT&G Corp., an acronym for Korea Tobacco & Ginseng Corporation, is a unique entity in the global business landscape, epitomizing a fascinating blend of tradition and modernity. Born in South Korea, KT&G has transcended its origins to become a formidable player in both the tobacco and health supplement industries. Its roots stretch back to 1899 when it began as a state-run monopoly in Korea focusing on tobacco. Over the decades, it has successfully evolved, strategically privatizing its operations in 2002. Today, KT&G is a publicly traded company that has successfully diversified its portfolio by expanding into the fields of cosmetics and biotechnology, though tobacco and ginseng remain its flagship products. Its prowess lies in understanding the delicate balance between sectors that are not typically seen together: the addictive allure of tobacco and the wellness attributes of Korean ginseng. The financial engine of KT&G is primarily fueled by its tobacco division, which produces a vast array of cigarette brands that cater to varying consumer preferences across the globe. This segment is a powerhouse, with products that are distributed in over 50 countries, ensuring a steady stream of revenue. On the other hand, the ginseng business is another pillar of KT&G's economic structure, driven by the growing global demand for natural health supplements, including its renowned CheongKwanJang brand, which has become synonymous with quality and reliability in ginseng products. This dual approach enables KT&G to mitigate risks associated with each industry's specific challenges, creating a robust and diversified revenue model. It's a strategic maneuver allowing KT&G to capitalize on the burgeoning wellness trend while maintaining its dominant position in the tobacco market.
See Also
What is KT&G Corp's Note Receivable?
Note Receivable
109.4B
KRW
Based on the financial report for Dec 31, 2025, KT&G Corp's Note Receivable amounts to 109.4B KRW.
What is KT&G Corp's Note Receivable growth rate?
Note Receivable CAGR 10Y
8%
Over the last year, the Note Receivable growth was 16%. The average annual Note Receivable growth rates for KT&G Corp have been 27% over the past three years , 14% over the past five years , and 8% over the past ten years .